BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Income statement
Balance sheet
Cash flow

Income statement

All numbers in thousands
Total revenue6,15514,07925,421
Cost of revenue---
Gross profit6,15514,07925,421
Operating expenses
Research development204,775134,03862,574
Selling general and administrative69,21049,07823,473
Total operating expenses---
Operating income or loss-267,830-169,037-60,626
Income from continuing operations
Total other income/expenses net3,7112,314120
Earnings before interest and taxes-264,119-166,723-60,506
Interest expense---
Income before tax-264,119-166,723-60,506
Income tax expense-61260-11,797
Minority interest---
Net income from continuing ops-263,507-166,783-48,709
Non-recurring events
Discontinued operations---
Extraordinary items---
Effect of accounting changes---
Other items---
Net income
Net income-263,507-166,783-48,709
Preferred stock and other adjustments---
Net income applicable to common shares-263,507-166,783-48,709
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes